Michael Novogratz’s Fortress Investment Trims Stake in Cardiome Pharma (CRME)

A recent 13G filing shows that Michael Novogratz’s Fortress Investment Group trimmed its passive stake in Cardiome Pharma Corp. (NASDAQ:CRME) to 981,600 shares from 2.5 million shares held previously. Fortress Investment currently holds 6.5% of the company’s common stock.

top hedge funds

In November 2013, Fortress initiated position in Cardiome, disclosing ownership of 2.5 million shares, equal to almost 17% of the stock. Since the position has been revealed the stock has gained over 40%.

Cardiome Pharma Corp. (NASDAQ:CRME) is an integrated, commercial, specialty pharmaceutical company, based in Canada. Earlier this week, in a press release, Cardiome Pharma Corp. (NASDAQ: CRME) and CarCor Investment Holdings LLC announced the closing of their previously announced prospectus offering of 1.5 million common shares for gross proceeds of $13.5 million and 1.5 million shares in a secondary offering from CarCor for gross proceeds of $13.5 million both at roughly $9 per common share, for a combined offering of approximately $27.0 million. The company intends to use the net proceeds of the primary offering for working capital and general corporate purposes, including to fund expansions in Europe and other parts of the world.

Cardiome and CarCor have granted the underwriters an over-allotment option to purchase, pro rata from each of Cardiome and CarCor, up to an additional 15% or an aggregate of up to 450,000 common shares of the offering on the same terms and conditions, exercisable in whole or in part at any time for a period of 30 days following closing of the offering.

Analysts at Canaccord Genuity upgraded shares of Cardiome Pharma Corp (NASDAQ:CRME) to a buy rating from its previous hold rating. R.F Lafferty started coverage on the stock with a ‘buy’ recommendation with a target price of $9 per share.

Other significant stakeholders of Cardiome Pharma Corp include Phill Gross and Robert’s Atchinson’s Adage Capital Management, which holds 1.3 million shares, followed by Casey Nelson’s Alistair Capital, with ownership of 917,000 shares. Next up is Renaissance Technologies, led by billionaire Jim Simons, which owns approximately 218,900 shares of the pharma company.

Fortress Investment Group began as a private equity firm in 1998. It was founded by Wesley R. Edens, a former partner at BlackRock Financial; Robert Kauffman, a managing director at UBS; and Randal A. Nardone, also a managing director at UBS. Princeton graduates Michael Novogratz and Pete Briger, both former partners at Goldman Sachs, were brought in four years later to run Fortress Investment’s hedge funds as well as its new real estate-related investments and debt securities. The fund is heavily weighted towards the financial and healthcare sectors. It had $6.5 billion in its equity portfolio at the end of last year.

Last month, Fortress Investment upped its position in Brookdale Senior Living Inc. (NYSE:BKD) to 20.3 million shares from 17.6 million held earlier. The new position amounts to 16.3% of the company’s common stock.

Some of the largest investments of the fund as at the end of the fourth quarter of 2013 include Nationalstar Manufacturing Holdings Inc (NYSE:NSM) in which Fortress owns approximately 67.8 million shares worth $2.5 billion. The fund also holds 73.4 million shares of Springleaf Holdings Inc. (NYSE:LEAF) with a reported value of $1.9 billion.

Disclosure:none

Recommended Reading:

Cadence Pharmaceuticals, Inc. (CADX), Griffin Land & Nurseries, Inc. (GRIF) and Three Other Moves From Mario Gabelli and GAMCO Investors

Odey Asset Management Reduces Position in LSE-listed STV Group Plc. (STVG)

Ardsley Partners Trims Stake to 6.8% in World Energy Solutions (XWES)

Dividend Stock Alert - Billionaire Robbins' Top Dividend Idea With 70% Upside Potential

Get Paid 3.5% Per Year While Waiting For The Stock Appreciate 70%

Larry Robbins' Glenview Capital Opportunity Fund returned 101.7% in 2013 and Robbins personally made $750 million. The same fund returned 25.3% in 2014. In this FREE REPORT we will share Robbins' top dividend idea that yields 3.5% and has been increasing its dividends for 39 consecutive years. Robbins thinks the stock has the potential to appreciate 70%.

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Click here to Read Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 74 percentage points in 2.5 years. Our beta is only 1.2 (download a FREE newsletter and see the details inside)

Lists

Best Selling Magazines in the World

Shortest People in History

The Most Celebrated Holidays in the World

Most Expensive Handbag Brands in the World

Top Selling Comic Book Issues of this Century

The Most Powerful Women in Politics

Best Paid DJs

Most Rebellious Female Artists

Best Paid TV Actresses of 2014

Best Paid Actors of 2014

Most Expensive Horses in the World

Tallest People Ever

Most Encouraging Feminist Celebrities

Best Paid Supermodels of 2014

Top 10 Suburbs for Retirement in 2015

10 Wealthiest Cities in America

Top 10 TED Talks for Entrepreneurs

Best TED Talks on Education

25 Most Dangerous Places to Live in America

Top 10 Ski Resorts in the United States – 2014 List

Top 10 Most Remote Places in the World

Most Visited Museums in the United States

Wealthiest Photographers in the World

Most Famous Gay Athletes

The World’s Most Famous Circuses

Best Hair Stylists

Most Popular NASCAR Drivers

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!